In an interview to CNBC-TV18, YK Hamied, chairman and managing director of Cipla says, the company is launching an anti-malarial drug in India. "Today, being the World Malaria day, we are launching a new combination drug along with our partners who are based in Geneva called DNDI," he asserts.
first published: Apr 25, 2012 02:08 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty fails to defend 25,100, breaks 4-day surge | Closing Bell
Live: Can bulls continue to defend Nifty's 25,100 zone? | Opening Bell
Live: Nifty holds gain for 4th day, above 25,100 on weekly expiry day | Closing bell
Zoho CEO Mani Vembu On Why India Needs Arattai, Growth Surge And Integrating Businesses | Exclusive
